Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/6877
Title: Risk of recurrence in patients with an unprovoked tonic–clonic seizure and generalized epileptiform discharges on EEG
Authors: Jomaa, Najo
Nasreddine, Wassim
Hmeimess, Ghassan
Beaini, Shawkat
Beydoun, Ayman
Hotait, Mostafa
Wazne, Jaafar
Beydoun, Ahmad
Affiliations: Faculty of Medicine 
Keywords: Antiseizure medication
Electroencephalogram
First seizure
Generalized spike–wave discharge
Recurrence rate
Issue Date: 2023-08
Publisher: Wiley Online Library
Part of: Epilepsia
Volume: 64
Issue: 8
Start page: 2153
End page: 2161
Abstract: 
Objective: The decision to initiate treatment in patients with a first unprovoked seizure remains controversial. Studies have reported a recurrence rate ranging from 21%–50%, but most have included patients with different etiologies, electroencephalography (EEG) findings, and seizure types. This study aimed to determine the risk of recurrence in patients with a first unprovoked generalized tonic–clonic (GTC) seizure with evidence of generalized spike–wave discharges (GSWDs) on EEG and compare the efficacy of antiseizure medications (ASMs) in preventing recurrence. Methods: This prospective study included consecutive patients who presented with a single GTC seizure, evidence of GSWDs on EEG, and a follow-up period of at least 1 year. All patients underwent extensive evaluation, including a 3-hour sleep-deprived video-EEG recording and an epilepsy protocol brain magnetic resonance imaging (MRI). Treatment with ASMs was recommended for all patients. The decision regarding the specific ASM to be used was left to the treating physician's discretion. Results: A total of 57 patients with a median age of 19 years were included. A total of 41 patients agreed to be started on an ASM while 16 declined. Seizure recurred in 6 of 41 patients (14.6%) in the treated group compared to 11 of 16 (68.8%) in the untreated group (p =.00006). Valproate was significantly more efficacious than levetiracetam or lamotrigine (p =.04). Of the 15 patients who discontinued ASM treatment after remaining seizure-free for an average of 30 months, 6 (40%) experienced a seizure recurrence. Significance: Patients with a first unprovoked GTC seizure and evidence of GSWDs on EEG have a high risk of recurrence if left untreated. Valproate is the most efficacious ASM for preventing recurrence in this population. A sizeable proportion of patients can be successfully tapered off medication after a period of seizure freedom. This study provides valuable information for guiding treatment decisions in this patient population.
URI: https://scholarhub.balamand.edu.lb/handle/uob/6877
ISSN: 00139580
DOI: 10.1111/epi.17671
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

SCOPUSTM   
Citations

4
checked on Apr 20, 2024

Record view(s)

30
checked on Apr 22, 2024

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.